Literature DB >> 29772577

Incidental Detection of Dent-2 Disease in an Infant with Febrile Proteinuria.

Shpetim Salihu1, Katerina Tosheska2, Svetlana Cekovska2, Velibor Tasic3.   

Abstract

OBJECTIVE: Febrile proteinuria is functional proteinuria and is seen as a transitory phenomenon during acute febrile illness, mainly viral infections. It is a benign phenomenon and clears promptly with resolution of the infection. CLINICAL PRESENTATION AND INTERVENTION: In this report, we present a patient who was thought to have febrile proteinuria. Persistence of significant proteinuria after resolution of the infection prompted biochemical and genetic workup which led to the diagnosis of Dent-2 disease.
CONCLUSION: We recommend the use of SDS-PAGE (sodium dodecyl sulfate electropheresis) for the detection of low molecular weight proteinuria.
© 2018 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Dent-2 disease; Functional proteinuria; Infants; OCRL mutation; SDS-PAGE

Mesh:

Year:  2018        PMID: 29772577      PMCID: PMC6167689          DOI: 10.1159/000490147

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  10 in total

1.  Does Dent disease remain an underrecognized cause for young boys with focal glomerulosclerosis?

Authors:  Kaori Kubo; Tomomi Aizawa; Shojiro Watanabe; Koji Tsugawa; Kazushi Tsuruga; Etsuro Ito; Kensuke Joh; Hiroshi Tanaka
Journal:  Pediatr Int       Date:  2016-06-21       Impact factor: 1.524

2.  OCRL1 mutation in a boy with Dent disease, mild mental retardation, but without cataracts.

Authors:  Vladimir J Lozanovski; N Ristoska-Bojkovska; P Korneti; Z Gucev; V Tasic
Journal:  World J Pediatr       Date:  2011-08-07       Impact factor: 2.764

3.  Proteinuria in Children: Evaluation and Differential Diagnosis.

Authors:  Alexander K C Leung; Alex H C Wong; Stefani S N Barg
Journal:  Am Fam Physician       Date:  2017-02-15       Impact factor: 3.292

4.  Clinical and laboratory features of Macedonian children with OCRL mutations.

Authors:  Velibor Tasic; Vladimir J Lozanovski; Petar Korneti; Nadica Ristoska-Bojkovska; Vesna Sabolic-Avramovska; Zoran Gucev; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2011-01-20       Impact factor: 3.714

5.  Novel OCRL1 mutations in patients with the phenotype of Dent disease.

Authors:  Boris Utsch; Arend Bökenkamp; Marcus R Benz; Nesrin Besbas; Jörg Dötsch; Ingo Franke; Stefan Fründ; Faysal Gok; Bernd Hoppe; Stephanie Karle; Eberhard Kuwertz-Bröking; Guido Laube; Margarita Neb; Matti Nuutinen; Fatih Ozaltin; Wolfgang Rascher; Troels Ring; Velibor Tasic; Joanna A E van Wijk; Michael Ludwig
Journal:  Am J Kidney Dis       Date:  2006-12       Impact factor: 8.860

6.  Renal manifestations of Dent disease and Lowe syndrome.

Authors:  Hee Yeon Cho; Bum Hee Lee; Hyun Jin Choi; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2007-11-24       Impact factor: 3.714

Review 7.  Evaluation of hematuria and proteinuria: how should a pediatrician proceed?

Authors:  Raymond Quigley
Journal:  Curr Opin Pediatr       Date:  2008-04       Impact factor: 2.856

8.  Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.

Authors:  Detlef Bockenhauer; Arend Bokenkamp; William van't Hoff; Elena Levtchenko; Joana E Kist-van Holthe; Velibor Tasic; Michael Ludwig
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-14       Impact factor: 8.237

9.  Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria.

Authors:  Takashi Sekine; Fusako Komoda; Kenichiro Miura; Junko Takita; Mitsunobu Shimadzu; Takeshi Matsuyama; Akira Ashida; Takashi Igarashi
Journal:  Nephrol Dial Transplant       Date:  2013-09-29       Impact factor: 5.992

Review 10.  The oculocerebrorenal syndrome of Lowe: an update.

Authors:  Arend Bökenkamp; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2016-03-24       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.